NCI-H716
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1581
|
Homo sapiens (Human)
|
Cecum adenocarcinoma
|
Characteristics: Secretes high level of glucagon-like peptide 1 (GLP-1) (PubMed=29787053)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel.
|
PMID:1359704 PMID:3479249 PMID:8806089 PMID:8806092 PMID:8806095 PMID:16418264 PMID:18258742 PMID:19927377 PMID:20164919 PMID:20215515 PMID:20606684 PMID:22460905 PMID:23272949 PMID:24755471 PMID:25485619 PMID:25877200 PMID:25926053 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28854368 PMID:29101300 PMID:29444439 PMID:29787053 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
NCI H716, H716, H-716, NCIH716 |
|
|
BTO:BTO_0004747, CLO:CLO_0008108, EFO:EFO_0002301, CLDB:cl3658, AddexBio:C0009022/5006, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CCL-251, BCRC:60517, BioGRID_ORCS_Cell_line:520, BioSample:SAMN03473254, BioSample:SAMN10987641, cancercelllines:CVCL_1581, CCRID:1101HUM-PUMC000359, CCRID:3101HUMTCHu210, CCTCC:GDC0163, Cell_Model_Passport:SIDM00779, ChEMBL-Cells:CHEMBL3308297, ChEMBL-Targets:CHEMBL2366106, CLS:305079, ColonAtlas:NCIH716, Cosmic:687536, Cosmic:908458, Cosmic:1995589, Cosmic:2302001, Cosmic-CLP:908458, DepMap:ACH-000491, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:908458, GEO:GSM513917, GEO:GSM514304, GEO:GSM887443, GEO:GSM888523, GEO:GSM1346850, GEO:GSM1374759, GEO:GSM1448144, GEO:GSM1670259, IARC_TP53:21579, IARC_TP53:21743, IGRhCellID:NCIH716, KCLB:10251, LiGeA:CCLE_373, LINCS_LDP:LCL-1339, PharmacoDB:NCIH716_1130_2019, PRIDE:PXD005235, PRIDE:PXD005354, PRIDE:PXD005355, PRIDE:PXD030304, Progenetix:CVCL_1581, PubChem_Cell_line:CVCL_1581, SKY/M-FISH/CGH:5013, Ubigene:YC-C112, Wikidata:Q54908110 |
|
|
CVCL_1581 |
2026-09-12 05:49:57 |
109 |
NCI-H647
Resource Report
Resource Website
10+ mentions
Possibly Discontinued
|
RRID:CVCL_1574
|
Homo sapiens (Human)
|
Lung adenosquamous carcinoma
|
Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1311061 PMID:1565469 PMID:3335022 PMID:8806092 PMID:11030152 PMID:20215515 PMID:22460905 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29444439 PMID:29681454 PMID:30894373 PMID:31068700 PMID:31803961 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
H647, H-647, H647ell, NCIH647 |
|
|
BTO:BTO_0005294, CLO:CLO_0008100, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-5834, BioSample:SAMN03471319, BioSample:SAMN10988271, cancercelllines:CVCL_1574, Cell_Model_Passport:SIDM01125, ChEMBL-Cells:CHEMBL3308691, ChEMBL-Targets:CHEMBL614999, CLS:305130, Cosmic:722060, Cosmic:903577, Cosmic:931370, Cosmic:980966, Cosmic:1032438, Cosmic:1146921, Cosmic:1891887, Cosmic-CLP:1240191, DepMap:ACH-000378, EGA:EGAS00001000978, GDSC:1240191, GEO:GSM206497, GEO:GSM274809, GEO:GSM274810, GEO:GSM434311, GEO:GSM513970, GEO:GSM514351, GEO:GSM784213, GEO:GSM794295, GEO:GSM817076, GEO:GSM827587, GEO:GSM844657, GEO:GSM844658, GEO:GSM887438, GEO:GSM888518, GEO:GSM1374758, GEO:GSM1670254, IARC_TP53:996, IGRhCellID:H647GEO, KCLB:90647, LiGeA:CCLE_620, LINCS_LDP:LCL-1629, PharmacoDB:NCIH647_1124_2019, PRIDE:PXD030304, Progenetix:CVCL_1574, PubChem_Cell_line:CVCL_1574, Wikidata:Q54908092 |
|
|
CVCL_1574 |
2026-09-12 05:49:57 |
11 |
NCI-H322
Resource Report
Resource Website
10+ mentions
Discontinued Possibly Discontinued
|
RRID:CVCL_1556
|
Homo sapiens (Human)
|
Minimally invasive lung adenocarcinoma
|
Caution: We are not certain that NCI-H322 and NCI-H322M are identical., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1311061 PMID:1565469 PMID:2386953 PMID:2388294 PMID:3335022 PMID:7972006 PMID:8806092 PMID:10536175 PMID:11005564 PMID:11030152 PMID:11416159 PMID:19472407 PMID:20215515 PMID:20557307 PMID:20679594 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:26589293 PMID:29681454 PMID:30894373 PMID:31068700 PMID:31803961
|
Cancer cell line
|
Male |
H322, H-322, H322T, NCI-H322T, NCIH322T, NCI-322, NCIH322 |
|
|
BTO:BTO_0003007, CLO:CLO_0008083, EFO:EFO_0006691, CLDB:cl3655, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CRL-5806, BioGRID_ORCS_Cell_line:525, BioSample:SAMN03471699, BioSample:SAMN03471740, BioSample:SAMN03473287, BioSample:SAMN10987678, cancercelllines:CVCL_1556, ChEMBL-Cells:CHEMBL3307405, ChEMBL-Targets:CHEMBL614573, CLS:305839, Cosmic:687822, Cosmic:801589, Cosmic:844830, Cosmic:876143, Cosmic:903571, Cosmic:917976, Cosmic:929972, Cosmic:932922, Cosmic:934547, Cosmic:980962, Cosmic:1028935, Cosmic:1032434, Cosmic:1146913, Cosmic:1152500, Cosmic:1239903, Cosmic:1802317, Cosmic:1870261, Cosmic:1891884, Cosmic:2042867, Cosmic:2125250, Cosmic:2648438, Cosmic:2668312, DepMap:ACH-000837, ECACC:95111734, EGA:EGAS00001000610, GEO:GSM171876, GEO:GSM171877, GEO:GSM206490, GEO:GSM253358, GEO:GSM274757, GEO:GSM274758, GEO:GSM434333, GEO:GSM784245, GEO:GSM794282, GEO:GSM817070, GEO:GSM827434, GEO:GSM887426, GEO:GSM888506, GEO:GSM1374741, IARC_TP53:516, IGRhCellID:NCIH322, KCLB:90322, LiGeA:CCLE_305, LINCS_LDP:LCL-1798, PharmacoDB:NCIH322_1105_2019, Progenetix:CVCL_1556, PubChem_Cell_line:CVCL_1556, Wikidata:Q54908033 |
|
|
CVCL_1556 |
2026-09-12 05:49:55 |
20 |
NCI-H69
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1579
|
Homo sapiens (Human)
|
Lung small cell carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1662924 PMID:1845952 PMID:1847845 PMID:2388294 PMID:2473086 PMID:2574988 PMID:2594029 PMID:2985257 PMID:2985258 PMID:2986243 PMID:3034934 PMID:3335022 PMID:6108156 PMID:6148444 PMID:6270685 PMID:6272398 PMID:6713399 PMID:7736387 PMID:7903701 PMID:8263009 PMID:8626706 PMID:8712684 PMID:8784480 PMID:8806092 PMID:8806103 PMID:9212023 PMID:9413215 PMID:9559344 PMID:9744504 PMID:9815546 PMID:10037197 PMID:10358721 PMID:10536175 PMID:11005564 PMID:11030152 PMID:11414198 PMID:12569360 PMID:17426248 PMID:19394761 PMID:19446745 PMID:19472407 PMID:20164919 PMID:20215515 PMID:20557307 PMID:20615970 PMID:22460905 PMID:22961666 PMID:23716474 PMID:25877200 PMID:26589293 PMID:27247353 PMID:27397505 PMID:28196595 PMID:28766886 PMID:30038707 PMID:30894373 PMID:31068700 PMID:31803961 PMID:32351780 PMID:32586373 PMID:34439128 PMID:35839778 PMID:39154123
|
Cancer cell line
|
Male |
NCI-H-69, NCI H69, H69, H-69, NCIH69, NCI-HUT-69, H69/P, NCI-H69C, H69C, H69c |
|
|
BTO:BTO_0003022, CLO:CLO_0003609, CLO:CLO_0008105, EFO:EFO_0002300, CLDB:cl1552, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-119, BioSample:SAMN03473085, BioSample:SAMN10988132, cancercelllines:CVCL_1579, CCRID:1101HUM-PUMC000358, Cell_Model_Passport:SIDM01121, ChEMBL-Cells:CHEMBL3307712, ChEMBL-Targets:CHEMBL614805, CLS:300185, Cosmic:688027, Cosmic:713879, Cosmic:755459, Cosmic:801610, Cosmic:808518, Cosmic:844545, Cosmic:844817, Cosmic:876167, Cosmic:877351, Cosmic:918010, Cosmic:929160, Cosmic:1006522, Cosmic:1021849, Cosmic:1152461, Cosmic:1175859, Cosmic:1212189, Cosmic:1219096, Cosmic:1239934, Cosmic:1434964, Cosmic:1571755, Cosmic:1609516, Cosmic:1995588, Cosmic:1998272, Cosmic:2125215, Cosmic:2239080, Cosmic:2648017, Cosmic:2668341, Cosmic-CLP:688027, DepMap:ACH-000358, ECACC:91091802, EGA:EGAS00001000978, GDSC:688027, GEO:GSM169443, GEO:GSM380498, GEO:GSM536334, GEO:GSM784197, GEO:GSM794269, GEO:GSM827305, GEO:GSM844659, GEO:GSM845550, GEO:GSM887442, GEO:GSM888522, GEO:GSM1670258, GEO:GSM1887950, GEO:GSM1887978, IARC_TP53:328, IGRhCellID:NCIH69, IZSLER:BS TCL 172, KCLB:30119, LiGeA:CCLE_927, LINCS_LDP:LCL-1859, NCI-DTP:NCI-H69, PharmacoDB:NCIH69_1129_2019, PRIDE:PXD011896, PRIDE:PXD015270, PRIDE:PXD030304, Progenetix:CVCL_1579, PubChem_Cell_line:CVCL_1579, Wikidata:Q38568854 |
|
|
CVCL_1579 |
2026-09-12 05:49:57 |
168 |
NCI-H929
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1600
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Characteristics: Produces IgA kappa., Population: Caucasian., Part of: RAS genetic alteration cell panel (ATCC TCP-1031)., Part of: MYC genetic alteration cell panel (ATCC TCP-1035)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:2423157 PMID:3275865 PMID:8806089 PMID:8806092 PMID:8943038 PMID:10087940 PMID:10936422 PMID:11157491 PMID:12068308 PMID:16956823 PMID:17171682 PMID:17692805 PMID:18647998 PMID:18700954 PMID:19306352 PMID:21173094 PMID:22460905 PMID:25485619 PMID:25688540 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30545397 PMID:30894373 PMID:31068700 PMID:31978347 PMID:32123307 PMID:35839778
|
Cancer cell line
|
Female |
NCI H929, NCIH929, H929, H-929 |
|
|
BTO:BTO_0002416, CLO:CLO_0008127, EFO:EFO_0001221, CLDB:cl3661, CLDB:cl3662, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-1088, ATCC:CRL-3580, ATCC:CRL-9068, BCRC:60386, BioSample:SAMN03473361, BioSample:SAMN10988115, cancercelllines:CVCL_1600, CCRID:1101HUM-PUMC000360, CCRID:4201HUM-CCTCC00300, CCTCC:GDC0300, Cell_Model_Passport:SIDM01148, ChEMBL-Cells:CHEMBL4295412, ChEMBL-Targets:CHEMBL4296391, CLS:305236, Cosmic:720769, Cosmic:724825, Cosmic:759905, Cosmic:760391, Cosmic:760392, Cosmic:886085, Cosmic:888022, Cosmic:1070716, Cosmic:1424217, Cosmic:2081399, Cosmic:2302415, Cosmic:2367293, Cosmic:2391791, Cosmic:2809759, Cosmic-CLP:724825, DepMap:ACH-000050, DSMZ:ACC-163, DSMZCellDive:ACC-163, ECACC:95050415, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS197CBA, ENCODE:ENCBS571AQH, GDSC:724825, GEO:GSM143333, GEO:GSM290290, GEO:GSM562817, GEO:GSM887452, GEO:GSM888532, GEO:GSM1374767, GEO:GSM1670271, IARC_TP53:28520, LiGeA:CCLE_061, Lonza:47, PharmacoDB:NCIH929_1149_2019, PRIDE:PXD030304, Progenetix:CVCL_1600, PubChem_Cell_line:CVCL_1600, Wikidata:Q54908142 |
|
|
CVCL_1600 |
2026-09-12 05:49:57 |
474 |
NCI-H810
Resource Report
Resource Website
1+ mentions
Possibly Discontinued
|
RRID:CVCL_1590
|
Homo sapiens (Human)
|
Lung large cell carcinoma
|
Population: African American., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1311061 PMID:1563005 PMID:8806092 PMID:11030152 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31803961 PMID:35839778
|
Cancer cell line
|
Male |
H810, H-810, NCIH810 |
|
|
CLO:CLO_0008117, EFO:EFO_0002305, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-5816, BioSample:SAMN03471742, BioSample:SAMN03473000, BioSample:SAMN10987804, cancercelllines:CVCL_1590, Cell_Model_Passport:SIDM01116, ChEMBL-Cells:CHEMBL3308483, ChEMBL-Targets:CHEMBL1075546, Cosmic:755470, Cosmic:877413, Cosmic:925341, Cosmic:1995592, Cosmic-CLP:925341, DepMap:ACH-000789, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:925341, GEO:GSM827518, GEO:GSM887446, GEO:GSM888526, GEO:GSM1374762, GEO:GSM1374763, GEO:GSM1670265, GEO:GSM1682799, IARC_TP53:27195, IGRhCellID:NCIH810, KCLB:90810, LiGeA:CCLE_013, LINCS_HMS:50037, LINCS_LDP:LCL-1670, PharmacoDB:NCIH810_1138_2019, PRIDE:PXD030304, Progenetix:CVCL_1590, PubChem_Cell_line:CVCL_1590, Wikidata:Q54908124 |
|
|
CVCL_1590 |
2026-09-12 05:49:57 |
3 |
SiHa
Resource Report
Resource Website
1000+ mentions
|
CLS Cat# 305023, RRID:CVCL_0032
|
Homo sapiens (Human)
|
Human papillomavirus-related cervical squamous cell carcinoma
|
Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (PubMed=24201445)., Population: Japanese., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:833871 PMID:1394225 PMID:2990217 PMID:3029430 PMID:3029760 PMID:3518877 PMID:5529598 PMID:10423141 PMID:15531914 PMID:16957166 PMID:17311676 PMID:20164919 PMID:20215515 PMID:20429727 PMID:21439369 PMID:22412903 PMID:23881600 PMID:24134916 PMID:24201445 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28261610 PMID:29156801 PMID:30760827 PMID:30894373 PMID:31068700 PMID:35198691 PMID:35421932 PMID:35692560 PMID:35839778
|
Cancer cell line
|
Female |
Siha, SIHA |
CLS |
305023 |
BTO:BTO_0002210, CLO:CLO_0009017, EFO:EFO_0002379, MCCL:MCC:0000451, CLDB:cl4298, CLDB:cl4299, CLDB:cl4900, AddexBio:C0008002/372, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:HTB-35, BioGRID_ORCS_Cell_line:1796, BioSample:SAMN03473215, BioSample:SAMN10989623, cancercelllines:CVCL_0032, CCRID:1101HUM-PUMC000294, CCRID:1102HUM-NIFDC00092, CCRID:3101HUMSCSP5058, CCRID:3101HUMTCHu113, CCRID:4201HUM-CCTCC00110, CCTCC:GDC0110, Cell_Model_Passport:SIDM01093, ChEMBL-Cells:CHEMBL3307968, ChEMBL-Targets:CHEMBL612542, CLS:305023, Cosmic:760220, Cosmic:809229, Cosmic:846184, Cosmic:877467, Cosmic:925356, Cosmic:928911, Cosmic:930297, Cosmic:1019306, Cosmic:1131517, Cosmic:1193028, Cosmic:1201773, Cosmic:1324212, Cosmic:1995627, Cosmic:2301542, Cosmic:2660193, Cosmic:2791018, Cosmic:2816217, Cosmic-CLP:930297, DepMap:ACH-000556, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:930297, GEO:GSM113866, GEO:GSM226740, GEO:GSM226876, GEO:GSM253302, GEO:GSM675738, GEO:GSM685444, GEO:GSM722576, GEO:GSM722577, GEO:GSM723057, GEO:GSM723058, GEO:GSM1670422, GEO:GSM1716411, GEO:GSM1716412, GEO:GSM1716413, GEO:GSM1716414, GEO:GSM1716415, GEO:GSM1716416, GEO:GSM1716423, GEO:GSM1716424, GEO:GSM1716425, GEO:GSM1716426, GEO:GSM7701382, IARC_TP53:21696, ICLC:HTL98017, IGRhCellID:SiHa, IZSLER:BS TCL 112, KCB:KCB 2013026YJ, KCLB:30035, LINCS_LDP:LCL-1542, PharmacoDB:SiHa_1377_2019, PRIDE:PXD001806, PRIDE:PXD005466, PRIDE:PXD029773, PRIDE:PXD030304, PRIDE:PXD030885, Progenetix:CVCL_0032, PubChem_Cell_line:CVCL_0032, TOKU-E:3119, Wikidata:Q54953470 |
|
|
CVCL_0032 |
2026-09-12 06:06:34 |
1434 |
HCC366
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2059
|
Homo sapiens (Human)
|
Lung adenosquamous carcinoma
|
Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9559342 PMID:10987304 PMID:11314036 PMID:16187286 PMID:18083107 PMID:19472407 PMID:20215515 PMID:20557307 PMID:20624269 PMID:20679594 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:27602502 PMID:28196595 PMID:29681454 PMID:30038707 PMID:30894373 PMID:31068700 PMID:31803961 PMID:35839778
|
Cancer cell line
|
Female |
HCC-366, HCC0366, Hamon Cancer Center 366 |
|
|
CLO:CLO_0037011, EFO:EFO_0003131, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473079, BioSample:SAMN10988035, cancercelllines:CVCL_2059, Cell_Model_Passport:SIDM01070, CLS:302155, Cosmic:877261, Cosmic:903631, Cosmic:1146935, Cosmic:1239916, Cosmic:1518096, Cosmic:2125184, Cosmic:2559771, Cosmic-CLP:1240144, DepMap:ACH-000840, DSMZ:ACC-492, DSMZCellDive:ACC-492, EGA:EGAS00001000610, EGA:EGAS00001000978, GEO:GSM62335, GEO:GSM108871, GEO:GSM108872, GEO:GSM253363, GEO:GSM434261, GEO:GSM784223, GEO:GSM794379, GEO:GSM817114, GEO:GSM827365, GEO:GSM887053, GEO:GSM888123, GEO:GSM1669858, GEO:GSM2807229, GEO:GSM2807230, IARC_TP53:28330, IGRhCellID:HCC366_02GEO, KCLB:70366, KCLB:70966, LiGeA:CCLE_150, LINCS_LDP:LCL-1605, PharmacoDB:HCC366_458_2019, PRIDE:PXD030304, Progenetix:CVCL_2059, Wikidata:Q54881708 |
|
|
CVCL_2059 |
2026-09-12 06:07:39 |
3 |
23132/87
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1046
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8100658 PMID:11668190 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24807215 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
23132-87, 2313287, St 23132, St23132, 23132 |
|
|
CLO:CLO_0001202, EFO:EFO_0006528, CLDB:cl38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:822, BioSample:SAMN03470944, BioSample:SAMN03473375, BioSample:SAMN10988573, cancercelllines:CVCL_1046, Cell_Model_Passport:SIDM00980, ChEMBL-Cells:CHEMBL3308702, ChEMBL-Targets:CHEMBL1075382, Cosmic:910924, Cosmic:1995324, Cosmic:2484956, Cosmic-CLP:910924, DepMap:ACH-000948, DSMZ:ACC-201, DSMZCellDive:ACC-201, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910924, GEO:GSM827572, GEO:GSM886838, GEO:GSM887901, GEO:GSM1374371, GEO:GSM1374372, GEO:GSM1669566, IARC_TP53:21150, LiGeA:CCLE_415, LINCS_LDP:LCL-1532, PharmacoDB:2313287_13_2019, PRIDE:PXD030304, Progenetix:CVCL_1046, PubChem_Cell_line:CVCL_1046, Wikidata:Q54583395 |
|
|
CVCL_1046 |
2026-09-12 06:18:01 |
2 |
253J-BV
Resource Report
Resource Website
|
KCLB Cat# 80002, RRID:CVCL_7937
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Characteristics: Metastatic phenotype. Obtained after 5 serial passages of the parent cell line in the bladder of nude mice., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:7658585 PMID:26589293 PMID:29732388 PMID:31068700
|
Cancer cell line
|
Male |
253JB-V, 253J B-V, 253JBV, 253J-Bladder-V |
KCLB |
80002 |
BTO:BTO_0004894, EFO:EFO_0022648, ArrayExpress:E-MTAB-2770, BioSample:SAMN10987963, cancercelllines:CVCL_7937, Cell_Model_Passport:SIDM01624, Cosmic:846282, Cosmic:1082645, Cosmic:1938695, DepMap:ACH-000026, GEO:GSM136239, IARC_TP53:30015, KCLB:80002, LiGeA:CCLE_144, PharmacoDB:253JBV_15_2019, Wikidata:Q54583655 |
cvcl_7935 |
|
CVCL_7937 |
2026-09-12 06:18:04 |
0 |
253J-BV
Resource Report
Resource Website
|
RRID:CVCL_7937
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Characteristics: Metastatic phenotype. Obtained after 5 serial passages of the parent cell line in the bladder of nude mice., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:7658585 PMID:26589293 PMID:29732388 PMID:31068700
|
Cancer cell line
|
Male |
253JB-V, 253J B-V, 253JBV, 253J-Bladder-V |
|
|
BTO:BTO_0004894, EFO:EFO_0022648, ArrayExpress:E-MTAB-2770, BioSample:SAMN10987963, cancercelllines:CVCL_7937, Cell_Model_Passport:SIDM01624, Cosmic:846282, Cosmic:1082645, Cosmic:1938695, DepMap:ACH-000026, GEO:GSM136239, IARC_TP53:30015, KCLB:80002, LiGeA:CCLE_144, PharmacoDB:253JBV_15_2019, Wikidata:Q54583655 |
cvcl_7935 |
|
CVCL_7937 |
2026-09-12 06:18:04 |
0 |
253J
Resource Report
Resource Website
1+ mentions
Discontinued
|
ATCC Cat# HTB-108, RRID:CVCL_7935
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:66978 PMID:327080 PMID:571047 PMID:748774 PMID:944089 PMID:3518877 PMID:3708594 PMID:4431054 PMID:6244232 PMID:6582512 PMID:6935474 PMID:7459858 PMID:7658585 PMID:8873383 PMID:11207054 PMID:11416159 PMID:11921286 PMID:12127398 PMID:15846775 PMID:16885334 PMID:23401075 PMID:24035680 PMID:24367658 PMID:25997541 PMID:26589293 PMID:26621286 PMID:27270441 PMID:29732388 PMID:31068700
|
Cancer cell line
|
Male |
253j, 253-J, 253 J, 253J-P, 253J-Parental, 253J P, 253JP |
ATCC |
HTB-108 |
BTO:BTO_0004796, ArrayExpress:E-MTAB-2770, ATCC:HTB-108, BioSample:SAMN10987961, cancercelllines:CVCL_7935, Cell_Model_Passport:SIDM01529, Cosmic:715794, Cosmic:760476, Cosmic:845564, Cosmic:925827, Cosmic:928820, Cosmic:1016884, Cosmic:1046680, Cosmic:1082644, Cosmic:1285102, Cosmic:1285997, Cosmic:1927305, Cosmic:1938694, Cosmic:2050426, Cosmic:2057433, Cosmic:2444255, Cosmic:2685929, Cosmic:2700994, DepMap:ACH-000011, GEO:GSM136240, GEO:GSM1574546, GEO:GSM1574574, IARC_TP53:21034, KCLB:80001, LiGeA:CCLE_259, PharmacoDB:253J_14_2019, Wikidata:Q54583653 |
|
|
CVCL_7935 |
2026-09-12 06:18:04 |
5 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Ubigene Cat# YC-A012, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Ubigene |
YC-A012 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 06:15:45 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
BEI_Resources Cat# ARP-153, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
BEI_Resources |
ARP-153 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 06:15:45 |
39236 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
CCTCC Cat# GDC0152, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021 PMID:20215515 PMID:20555413 PMID:22949125 PMID:28489074 PMID:30894373 PMID:31068700 PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
CCTCC |
GDC0152 |
BTO:BTO_0003575, CLO:CLO_0003771, EFO:EFO_0022529, MCCL:MCC:0000193, AddexBio:T0011004/4929, ATCC:CRL-2190, BCRC:60097, BioGRID_ORCS_Cell_line:1711, BioSample:SAMN03472562, cancercelllines:CVCL_0302, CCRID:3101HUMSCSP511, CCRID:4201HUM-CCTCC00152, CCTCC:GDC0152, Cell_Model_Passport:SIDM01818, ChEMBL-Cells:CHEMBL4295396, ChEMBL-Targets:CHEMBL4296428, CLS:305021, Cosmic:2520628, DepMap:ACH-001087, ENCODE:ENCBS188NWH, GEO:GSM827261, GEO:GSM4009069, GEO:GSM4009073, KCB:KCB 200815YJ, KCLB:22190, Lonza:769, PharmacoDB:HK2_545_2019, Progenetix:CVCL_0302, PubChem_Cell_line:CVCL_0302, Ubigene:YC-C140, Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-09-12 06:15:49 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
KCLB Cat# 22190, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021 PMID:20215515 PMID:20555413 PMID:22949125 PMID:28489074 PMID:30894373 PMID:31068700 PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
KCLB |
22190 |
BTO:BTO_0003575, CLO:CLO_0003771, EFO:EFO_0022529, MCCL:MCC:0000193, AddexBio:T0011004/4929, ATCC:CRL-2190, BCRC:60097, BioGRID_ORCS_Cell_line:1711, BioSample:SAMN03472562, cancercelllines:CVCL_0302, CCRID:3101HUMSCSP511, CCRID:4201HUM-CCTCC00152, CCTCC:GDC0152, Cell_Model_Passport:SIDM01818, ChEMBL-Cells:CHEMBL4295396, ChEMBL-Targets:CHEMBL4296428, CLS:305021, Cosmic:2520628, DepMap:ACH-001087, ENCODE:ENCBS188NWH, GEO:GSM827261, GEO:GSM4009069, GEO:GSM4009073, KCB:KCB 200815YJ, KCLB:22190, Lonza:769, PharmacoDB:HK2_545_2019, Progenetix:CVCL_0302, PubChem_Cell_line:CVCL_0302, Ubigene:YC-C140, Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-09-12 06:15:49 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
ATCC Cat# CRL-2190, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021 PMID:20215515 PMID:20555413 PMID:22949125 PMID:28489074 PMID:30894373 PMID:31068700 PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
ATCC |
CRL-2190 |
BTO:BTO_0003575, CLO:CLO_0003771, EFO:EFO_0022529, MCCL:MCC:0000193, AddexBio:T0011004/4929, ATCC:CRL-2190, BCRC:60097, BioGRID_ORCS_Cell_line:1711, BioSample:SAMN03472562, cancercelllines:CVCL_0302, CCRID:3101HUMSCSP511, CCRID:4201HUM-CCTCC00152, CCTCC:GDC0152, Cell_Model_Passport:SIDM01818, ChEMBL-Cells:CHEMBL4295396, ChEMBL-Targets:CHEMBL4296428, CLS:305021, Cosmic:2520628, DepMap:ACH-001087, ENCODE:ENCBS188NWH, GEO:GSM827261, GEO:GSM4009069, GEO:GSM4009073, KCB:KCB 200815YJ, KCLB:22190, Lonza:769, PharmacoDB:HK2_545_2019, Progenetix:CVCL_0302, PubChem_Cell_line:CVCL_0302, Ubigene:YC-C140, Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-09-12 06:15:48 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
Ubigene Cat# YC-C140, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021 PMID:20215515 PMID:20555413 PMID:22949125 PMID:28489074 PMID:30894373 PMID:31068700 PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
Ubigene |
YC-C140 |
BTO:BTO_0003575, CLO:CLO_0003771, EFO:EFO_0022529, MCCL:MCC:0000193, AddexBio:T0011004/4929, ATCC:CRL-2190, BCRC:60097, BioGRID_ORCS_Cell_line:1711, BioSample:SAMN03472562, cancercelllines:CVCL_0302, CCRID:3101HUMSCSP511, CCRID:4201HUM-CCTCC00152, CCTCC:GDC0152, Cell_Model_Passport:SIDM01818, ChEMBL-Cells:CHEMBL4295396, ChEMBL-Targets:CHEMBL4296428, CLS:305021, Cosmic:2520628, DepMap:ACH-001087, ENCODE:ENCBS188NWH, GEO:GSM827261, GEO:GSM4009069, GEO:GSM4009073, KCB:KCB 200815YJ, KCLB:22190, Lonza:769, PharmacoDB:HK2_545_2019, Progenetix:CVCL_0302, PubChem_Cell_line:CVCL_0302, Ubigene:YC-C140, Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-09-12 06:15:49 |
1900 |
769-P
Resource Report
Resource Website
100+ mentions
|
ATCC Cat# CRL-1933, RRID:CVCL_1050
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:721102 PMID:1010528 PMID:6244232 PMID:17178751 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
769P, 769-p |
ATCC |
CRL-1933 |
BTO:BTO_0006376, CLO:CLO_0001485, EFO:EFO_0002099, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1933, BioGRID_ORCS_Cell_line:501, BioSample:SAMN03473275, BioSample:SAMN10988198, cancercelllines:CVCL_1050, CCRID:1101HUM-PUMC000333, CCRID:3101HUMSCSP5060, CCRID:3101HUMTCHu215, CCRID:4201HUM-CCTCC00103, CCTCC:GDC0103, Cell_Model_Passport:SIDM00803, ChEMBL-Cells:CHEMBL3308705, ChEMBL-Targets:CHEMBL1075385, CLS:300106, Cosmic:687935, Cosmic:801355, Cosmic:910922, Cosmic:982280, Cosmic:1779197, Cosmic:2520640, Cosmic-CLP:910922, DepMap:ACH-000411, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910922, GEO:GSM374479, GEO:GSM827256, GEO:GSM886844, GEO:GSM887908, GEO:GSM1669571, IARC_TP53:21154, IGRhCellID:769P, IZSLER:BS TCL 123, KCB:KCB 2013031YJ, LiGeA:CCLE_445, LINCS_LDP:LCL-1772, PharmacoDB:769P_27_2019, PRIDE:PXD030304, Progenetix:CVCL_1050, PubChem_Cell_line:CVCL_1050, Wikidata:Q54604830 |
|
|
CVCL_1050 |
2026-09-12 06:18:41 |
200 |
769-P
Resource Report
Resource Website
100+ mentions
|
IZSLER Cat# BS TCL 123, RRID:CVCL_1050
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:721102 PMID:1010528 PMID:6244232 PMID:17178751 PMID:20215515 PMID:22185343 PMID:22460905 PMID:22949125 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:27993170 PMID:28196595 PMID:28489074 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
769P, 769-p |
IZSLER |
BS TCL 123 |
BTO:BTO_0006376, CLO:CLO_0001485, EFO:EFO_0002099, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1933, BioGRID_ORCS_Cell_line:501, BioSample:SAMN03473275, BioSample:SAMN10988198, cancercelllines:CVCL_1050, CCRID:1101HUM-PUMC000333, CCRID:3101HUMSCSP5060, CCRID:3101HUMTCHu215, CCRID:4201HUM-CCTCC00103, CCTCC:GDC0103, Cell_Model_Passport:SIDM00803, ChEMBL-Cells:CHEMBL3308705, ChEMBL-Targets:CHEMBL1075385, CLS:300106, Cosmic:687935, Cosmic:801355, Cosmic:910922, Cosmic:982280, Cosmic:1779197, Cosmic:2520640, Cosmic-CLP:910922, DepMap:ACH-000411, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910922, GEO:GSM374479, GEO:GSM827256, GEO:GSM886844, GEO:GSM887908, GEO:GSM1669571, IARC_TP53:21154, IGRhCellID:769P, IZSLER:BS TCL 123, KCB:KCB 2013031YJ, LiGeA:CCLE_445, LINCS_LDP:LCL-1772, PharmacoDB:769P_27_2019, PRIDE:PXD030304, Progenetix:CVCL_1050, PubChem_Cell_line:CVCL_1050, Wikidata:Q54604830 |
|
|
CVCL_1050 |
2026-09-12 06:18:41 |
200 |